HPV Vaccine Does Not Appear to Encourage Risky Sexual Behavior

Release Date: December 13, 2011 | By Stephanie Stephens, Contributing Writer
Research Source: American Journal of Preventive Medicine

KEY POINTS

  • Young women ages 15 to 24 who received the HPV vaccine are no more likely to have begun having sex before the age of 15 than women who were not vaccinated, according to a new CDC study.
  • The number of lifetime sexual partners of women who received the HPV vaccine is no different than the number of lifetime sexual partners of unvaccinated women.
  • Young women ages 15 to19 who had the HPV vaccine were more likely than their peers who hadn’t been vaccinated to use condoms consistently during the four weeks prior to being surveyed.
Follow us on Facebook

Despite some assumptions to the contrary, young women who receive recommended vaccinations to prevent human papillomavirus (HPV) infection and associated cancers do not engage in more sexually risky behavior.

That is the cautious determination of a national study by The Centers for Disease Control & Prevention reported in the American Journal of Preventive Medicine. Lead study author Nicole C. Liddon, Ph.D. advised against drawing too broad a conclusion from the study, while explaining the motivation behind it.

“Because of perceived risk that young women would behave recklessly, parents, providers, policy-makers and other STD opponents raised concerns when the FDA first licensed and approved the HPV vaccine in 2006,” said Liddon. “It was clear that we needed to determine whether a relationship existed between being vaccinated against a sexually-transmitted disease and sexual behavior.”

HPV is the most common sexually transmitted disease in the U.S. with an estimated 6.2 million new infections annually, according to the study. The disease is linked to various cancers, including cervical and oral.

The authors obtained data from more than 1,200 women ages 15 to 24 years, interviewed as part of the National Survey of Family Growth (NSFG), including demographic and insurance information as well as specific information about sexual education and behaviors and receipt of the HPV vaccine. Age at vaccination was not available, making it uncertain whether HPV vaccination came before or after the start of sexual behaviors.

The researchers found no differences in sexual experience between the vaccinated and unvaccinated groups. Interestingly, among sexually active young women ages 15 to 19, those who had received the vaccine were more likely to report always using a condom in the past four weeks than those who had not received the vaccine.

Liddon and her colleagues also identified several health disparities, including the fact that young women with health insurance were more likely to receive the first dose of three recommended vaccinations than uninsured young women were. Additionally, women younger than 19 were nearly twice as likely to receive the vaccine as older women were.

“The study helps us answer a question that has captured the imagination of millions of Americans: Does HPV vaccine cause teen girls to have sex earlier or more often?” said Noel T. Brewer, associate professor of the department of health behavior and health education at the University of North Carolina, Chapel Hill. Brewer is also the director of Cervical Cancer-Free NC, a statewide initiative led by UNC's Gillings School of Global Public Health.

“Liddon and her colleagues clearly show that the vaccine does not promote sexual disinhibition,” Brewer continued. “These data are only a preliminary answer to the question as they are from a cross-sectional study of girls’ and women’s self-reports of vaccination.  However, the study offers us some of the only data on how HPV vaccine affects behavior.”

Liddon concurred, adding that “the lack of association between vaccination and risky behavior should help assuage concerns between disinhibition and the HPV vaccine. At the same time, we stress this isn’t a definitive answer as to whether or not a relationship exists. Further studies are needed to look at possible causality.”

TERMS OF USE: This story is protected by copyright. When reproducing any material, including interview excerpts, attribution to the Health Behavior News Service, part of the Center for Advancing Health, is required. While the information provided in this news story is from the latest peer-reviewed research, it is not intended to provide medical advice or treatment recommendations. For medical questions or concerns, please consult a health care provider.

# # #

For More Information:


Reach the Health Behavior News Service, part of the Center for Advancing Health, at hbns-editor@cfah.org or (202) 387-2829.

American Journal of Preventive Medicine: Contact the editorial office at (858) 534-9340 or eAJPM@ucsd.edu.

Liddon, N.C., Leichliter, J.S., Markowitz, L.E.  (2011). Human Papillomavirus Vaccine and Sexual Behavior Among Adolescent and Young Women. American Journal of Preventive Medicine, available online December 13.

Tags for this article:
Immunizations/Vaccinations   Teen Sexuality/Pregnancy/Contraception  



Comments on this article
Please note: CFAH reserves the right to moderate all comments posted to the Health Behavior News Service. Any inappropriate postings will be removed.

Philip says
December 14, 2011 at 8:20 PM

For even further reading on this, there is a series at the Health Journal Club by a doc who spent ten years at FDA, he doesn't think much of Gardasil.

http://healthjournalclub.com/category/gardasil/